Assignee
CELLTREND GMBH
DE·6 granted patents·5 pending applications·0 citations·filing 2015–2022
Top patents by PatentIndex Score
11 records- 0155US2025283892A1Diagnosis of alzheimer's disease by detecting auto-antibodies against y-box binding protein-1 (yb-1)CELLTREND GMBH·Filed 2022·Application pending·0 cites
- 0247US2022276251A1Diagnosis of cancer using detection of antibodies directed against pd1 and pd-l1CELLTREND GMBH·Filed 2020·Application pending·0 cites
- 0343US10732184B2Diagnosis of cancer by detecting auto-antibodies against PAR1CELLTREND GMBH·Filed 2015·Granted Aug 4, 2020·0 cites·25 claims
- 0443US10191058B2Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor receptor (VEGFR)CELLTREND GMBH·Filed 2015·Granted Jan 29, 2019·0 cites·14 claims
- 0542US10739346B2Diagnosis of cancer by detecting auto-antibodies against EGF-receptorCELLTREND GMBH·Filed 2015·Granted Aug 11, 2020·0 cites·13 claims
- 0642US10203343B2Diagnosis of cancer by detecting auto-antibodies against epidermal growth factor (EGF)CELLTREND GMBH·Filed 2015·Granted Feb 12, 2019·0 cites·9 claims
- 0737US10802020B2Diagnosis of chronic fatigue diseases using detection antibodies directed against a β-adrenergic receptorCELLTREND GMBH·Filed 2016·Granted Oct 13, 2020·0 cites·11 claims
- 0837US2021311048A1Anti-CXC chemokine receptor antibodies and C-X-C chemokines for the diagnosis of autoimmune disease and graft-versus-host diseaseCELLTREND GMBH·Filed 2017·Application pending·0 cites
- 0937US2019250172A1Prognosis of adverse outcomes by determination of midkine levels after cardiovascular stressCELLTREND GMBH·Filed 2016·Application pending·0 cites
- 1035US10261087B2Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor (VEGF)CELLTREND GMBH·Filed 2015·Granted Apr 16, 2019·0 cites·3 claims
- 1135US2018284117A1Method for diagnosing APS using determination of anti-PAR1 antibodiesCELLTREND GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELLTREND GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →